Effect of Influenza Vaccination in Preventing Laboratory-Confirmed Influenza Hospitalization in Patients With Diabetes Mellitus

被引:18
|
作者
Martinez-Baz, Ivan [1 ,2 ]
Navascues, Ana [3 ]
Eugenia Portillo, Maria [3 ]
Casado, Itziar [1 ,2 ]
Fresan, Ujue [1 ,2 ]
Ezpeleta, Carmen [3 ]
Castilla, Jesus [1 ,2 ]
机构
[1] Inst Salud Publ Navarra IdiSNA, Pamplona, Spain
[2] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain
[3] Complejo Hosp Navarra IdiSNA, Clin Microbiol Dept, Pamplona, Spain
基金
欧盟地平线“2020”;
关键词
diabetes mellitus; influenza; vaccine effectiveness; repeated vaccination; test-negative design; NAVARRE; SEASON; OUTPATIENT; INPATIENT; COHORT; SPAIN;
D O I
10.1093/cid/ciaa564
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. People with diabetes are at high risk of severe influenza complications. The influenza vaccination effect among diabetic patients remains inconclusive. We estimated the average effect of influenza vaccination status in the current and prior seasons in preventing laboratory-confirmed influenza hospitalization in diabetic patients. Methods. Patients attended in hospitals and primary healthcare centers with influenza-like illness were tested for influenza from the 2013-2014 to 2018-2019 seasons in Navarre, Spain. A test-negative case-control design in diabetic inpatients compared the influenza vaccination status in the current and 5 prior seasons between laboratory-confirmed influenza cases and negative controls. Vaccination status of influenza-confirmed cases was compared between diabetic inpatients and outpatients. Influenza vaccination effect was compared between diabetic patients and older (>= 60 years) or chronic nondiabetic patients. Results. Of 1670 diabetic inpatients tested, 569 (34%) were confirmed for influenza and 1101 were test-negative controls. The average effect in preventing influenza hospitalization was 46% (95% confidence interval [CI], 28%-59%) for current-season vaccination and 44% (95% CI, 20%-61%) for vaccination in prior seasons only in comparison to unvaccinated patients in the current and prior seasons. Among diabetic patients with confirmed influenza, current-season vaccination reduced the probability of hospitalization (adjusted odds ratio, 0.35; 95% CI,.15-.79). In diabetic patients, vaccination effect against influenza hospitalizations was not inferior to that in older or chronic nondiabetic patients. Conclusions. On average, influenza vaccination of diabetic population reduced by around half the risk of influenza hospitalization. Vaccination in prior seasons maintained a notable protective effect. These results reinforce the recommendation of influenza vaccination for diabetic patients.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [41] Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013
    El Omeiri, Nathalie
    Azziz-Baumgartner, Eduardo
    Thompson, Mark G.
    Clara, Wilfrido
    Cerpa, Mauricio
    Palekar, Rakhee
    Mirza, Sara
    Ropero-Alvarez, Alba Maria
    [J]. VACCINE, 2018, 36 (24) : 3555 - 3566
  • [42] Influenza-Associated Pneumonia in Children Hospitalized With Laboratory-Confirmed Influenza, 2003-2008
    Dawood, Fatimah S.
    Fiore, Anthony
    Kamimoto, Laurie
    Nowell, Mackenzie
    Reingold, Arthur
    Gershman, Ken
    Meek, James
    Hadler, James
    Arnold, Kathryn E.
    Ryan, Patricia
    Lynfield, Ruth
    Morin, Craig
    Baumbach, Joan
    Zansky, Shelley
    Bennett, Nancy M.
    Thomas, Ann
    Schaffner, William
    Kirschke, David
    Finelli, Lyn
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (07) : 585 - 590
  • [43] Maternal Antibodies Against Influenza in Cord Blood and Protection Against Laboratory-Confirmed Influenza in Infants
    Cowling, Benjamin J.
    Perera, Ranawaka A. P. M.
    Fang, Vicky J.
    Chu, Daniel K. W.
    Hui, Amelia P. W.
    Yeung, Anita P. C.
    Peiris, J. S. Malik
    Wong, Wilfred H. S.
    Chan, Eunice L. Y.
    Chiu, Susan S.
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (07) : 1741 - 1748
  • [44] Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination
    Jimenez-Jorge, Silvia
    de Mateo, Salvador
    Delgado-Sanz, Concha
    Pozo, Francisco
    Casas, Inmaculada
    Garcia-Cenoz, Manuel
    Castilla, Jesus
    Perez, Esteban
    Gallardo, Virtudes
    Rodriguez, Carolina
    Vega, Tomas
    Quinones, Carmen
    Martinez, Eva
    Maria Vanrell, Juana
    Gimenez, Jaume
    Castrillejo, Daniel
    del Carmen Serrano, Maria
    Mauro Ramos, Julian
    Larrauri, Amparo
    [J]. BMC INFECTIOUS DISEASES, 2013, 13
  • [45] Association Between the Use of Antibiotics, Antivirals, and Hospitalizations Among Patients With Laboratory-confirmed Influenza
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy
    Hardin, James
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (04) : 566 - 573
  • [46] Geographic Evaluation of Georgia Vaccination Disparity Among Laboratory-Confirmed Influenza Cases in a Children's Hospital
    Hoskins, Dorian
    Kaplan, Cynthia
    Pruitt, Andrea
    McCarter, Andrea
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S239 - S240
  • [47] Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season
    Drori, Y.
    Pando, R.
    Sefty, H.
    Rosenberg, A.
    Mendelson, E.
    Keinan-Boker, L.
    Shohat, T.
    Mandelboim, M.
    Glatman-Freedman, A.
    [J]. VACCINE, 2020, 38 (52) : 8387 - 8395
  • [48] Influenza Vaccine Effectiveness in Preventing Hospitalizations With Laboratory-Confirmed Influenza in Greece During the 2014-2015 Season: A Test-Negative Study
    Lytras, Theodore
    Kossyvakis, Athanasios
    Melidou, Angeliki
    Andreopoulou, Anastasia
    Exindari, Maria
    Gioula, Georgia
    Kalliaropoulos, Antonios
    Tryfinopoulou, Kyriaki
    Pogka, Vasiliki
    Spala, Georgia
    Malisiovas, Nikolaos
    Mentis, Andreas
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (11) : 1896 - 1904
  • [49] Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis
    Tabitha Woolpert
    Stephanie Brodine
    Hector Lemus
    Jill Waalen
    Patrick Blair
    Dennis Faix
    [J]. BMC Infectious Diseases, 12
  • [50] Determination of clinical and demographic predictors of laboratory-confirmed influenza with subtype analysis
    Woolpert, Tabitha
    Brodine, Stephanie
    Lemus, Hector
    Waalen, Jill
    Blair, Patrick
    Faix, Dennis
    [J]. BMC INFECTIOUS DISEASES, 2012, 12